𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MRI Findings of recurrent hepatocellular carcinoma after liver transplantation: Preliminary results

✍ Scribed by Chang Hee Lee; Lauren M. Brubaker; David A. Gerber; Young Mi Ku; Young Hoon Kim; Sang Soo Shin; Richard C. Semelka


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
371 KB
Volume
33
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Purpose

To describe the patterns of recurrence and serial magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) after liver transplantation.

Materials and Methods

All cases of recurrent HCC after transplantation between September 2002 and August 2009 that underwent MRI including precontrast T1, T2‐weighted images, and postgadolinium dynamic images were reviewed. On MRI we evaluated the characteristics and patterns of recurrent HCC after transplantation.

Results

A total 7 of 76 transplanted patients (four men, three women, age range, 45–63, mean 52.7 years) were included in this study. Four patients (57.1%) were identified to have a pattern of persistent local disease (PLD) near the transplanted liver, hepatorenal space, or suture site within 2.75 years (range, 2–4 years). Two patients showed recurrent HCC in the allograft alone within 5 years. One patient showed an intraperitoneal seeding (IPS) pattern which demonstrated diffuse peritoneal infiltration and thickening within 9 months. The diffuse metastatic disease (DMD) pattern was observed as a late manifestation of PLD and IPS. The most prominent volume of recurrent tumor burden was found in an extrahepatic (5 of 7 patients) compared to an intrahepatic (2 of 7 patients) location. The signal intensities and enhancement patterns did not exhibit change with disease progression.

Conclusion

We describe four patterns of recurrence of HCC following transplant. The most prominent tumor burden was located in an extrahepatic compared to an intrahepatic location. J. Magn. Reson. Imaging 2011;33:1399–1405. Β© 2011 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Recurrence of hepatocellular carcinoma a
✍ Sasan Roayaie; Jonathan D. Schwartz; Max W. Sung; Sukru H. Emre; Charles M. Mill πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

Very little is known about the natural history, effects of therapy, and survival after recurrence of hepatocellular carcinoma (HCC) after liver transplantation. All adult patients undergoing liver transplant from September 19, 1988, until September 19, 2002, were reviewed. Only patients with histolo

Impact of sirolimus on the recurrence of
✍ Srinath Chinnakotla; Gary L. Davis; Sugam Vasani; Peter Kim; Koji Tomiyama; Edmu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

Tumor recurrence after liver transplantation for hepatocellular carcinoma is associated with a poor prognosis. Because immunosuppression is a well-known risk factor for tumor growth, it is surprising that its possible role in the outcome of liver transplantation has been poorly evaluated. We perform